Konstantin Doronin
- Genetics top 1%
- Virus-based gene therapy research 37
- Biotechnology top 2%
- Cancer Research and Treatments 10
- Oncology top 5%
- CAR-T cell therapy research 8
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 11
- Molecular Biology top 10%
- Viral Infectious Diseases and Gene Expression in Insects 18
- RNA Interference and Gene Delivery 8
-
- Herpesvirus Infections and Treatments 3
-
- interferon and immune responses 3
- Co-authors
- William S.M. WoldAnn E. TollefsonKároly TóthMohan KuppuswamyElena V. ShashkovaDrew L. LichtensteinMichael A. BarryPéter Krajcsi
- Cited by
- GeneticsBiotechnologyOncology
- Partner nations
- United StatesRussiaSpain
In The Last Decade
Konstantin Doronin
40 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 78
- Genetics 1.5k
- Biotechnology 251
- Oncology 741
- Infectious Diseases 402
- Molecular Biology 1.2k
Countries citing papers authored by Konstantin Doronin
This map shows the geographic impact of Konstantin Doronin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantin Doronin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantin Doronin more than expected).
Fields of papers citing papers by Konstantin Doronin
This network shows the impact of papers produced by Konstantin Doronin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantin Doronin. The network helps show where Konstantin Doronin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Konstantin Doronin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 13 | |
| 2 | 2015 | 42 | |
| 3 | 2015 | 45 | |
| 4 | 2011 | 1 | |
| 5 | 2009 | 41 | |
| 6 | 2009 | 47 | |
| 7 | 2007 | 39 | |
| 8 | 2007 | 69 | |
| 9 | 2005 | 17 | |
| 10 | 2005 | 35 | |
| 11 | 2004 | 144 | |
| 12 | 2004 | 13 | |
| 13 | 2004 | 9 | |
| 14 | 2003 | 102 | |
| 15 | 2003 | 12 | |
| 16 | 2002 | 7 | |
| 17 | 2002 | 17 | |
| 18 | 1999 | 151 | |
| 19 | 1995 | 8 | |
| 20 | 1993 | 12 |
About Konstantin Doronin
Konstantin Doronin is a scholar working on Genetics, Biotechnology and Infectious Diseases, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (37 papers), Viral Infectious Diseases and Gene Expression in Insects (18 papers), Viral gastroenteritis research and epidemiology (11 papers), Cancer Research and Treatments (10 papers), CAR-T cell therapy research (8 papers), RNA Interference and Gene Delivery (8 papers), Herpesvirus Infections and Treatments (3 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Genetics (1.5k citations), Biotechnology (251 citations) and Oncology (741 citations). Konstantin Doronin has collaborated with scholars based in United States, Russia and Spain. Frequent co-authors include William S.M. Wold, Ann E. Tollefson, Károly Tóth, Mohan Kuppuswamy, Elena V. Shashkova, Drew L. Lichtenstein, Michael A. Barry, Péter Krajcsi, Peter A. Ward and Jacqueline F. Spencer. Their work appears in journals such as Science, Cancer Research and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.